SCHEMBL8535598

SCHEMBL8535598

N#Cc1ccc(-c2ncc[nH]2)c(N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.46
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
EGLN2 Q96KS0 2/20 0.44
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
MAP3K14 Q99558 2/20 0.40
HCRTR1 O43613 1/20 0.39
HCRTR2 O43614 1/20 0.39
CSNK1A1 P48729 1/20 0.39
TYRO3 Q06418 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
IMPDH2 P12268 1/20 0.38
IMPDH1 P20839 1/20 0.38
NISCH Q9Y2I1 2/20 0.37
MTOR P42345 1/20 0.37
ADK P55263 1/20 0.37
METAP2 P50579 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31486076 0.79 CYP19A1 (0.45) CYP19A1CYP11B1CYP11B2EGLN2PDE4A
SCHEMBL5248703 0.78 CSNK1A1 (0.44) CSNK1A1TYRO3DYRK1BNISCHMTOR
SCHEMBL8536429 0.75 VCAM1 (0.50) CYP19A1CYP11B1CYP11B2PDE4APDE4B
SCHEMBL8539349 0.75 HCRTR1 (0.40) CYP19A1CYP11B1CYP11B2EGLN2PDE4A
SCHEMBL21657456 0.75 ADRA2A (0.49) CSNK1A1TYRO3DYRK1BNISCHMTOR
SCHEMBL8537063 0.75 NR4A2 (0.43) CSNK1A1TYRO3DYRK1BNISCHMTOR
SCHEMBL22636621 0.75 CLK4 (0.51) EGLN2MAP3K14KDM4EALDH1A1GAA
SCHEMBL378124 0.74 NISCH (0.58) CYP19A1CYP11B2PDE4APDE4BPDE4C
SCHEMBL8540558 0.74 VCAM1 (0.46) CYP19A1CYP11B1CYP11B2PDE4APDE4B
SCHEMBL8539601 0.74 CYP19A1 (0.41) CYP19A1CYP11B1CYP11B2EGLN2PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0857171-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1998-08-12 EP disclosed
WO-1997015555-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1997-05-01 WO disclosed